esmo.org
Programme
ESMO Advanced Course on Individualising the Therapeutic Approach in Patients with NENs
BARCELONA SPAIN
14-15 JUNE 2019
Co-ChairsNicola Fazio, ITJuan Valle, UK
ESMO ADVANCED COURSE PROGRAMME
Barcelona, Spain
14-15 June 2019
CO-CHAIRS: Nicola Fazio, Italy SPEAKERS: Guido Bonomo, Italy
Juan Valle, United Kingdom Jaume Capdevila Castillon, Spain
Simona Glasberg, Israel
Prakash Manoharan, United Kingdom
Massimo Milione, Italy
Els Nieveen van Dijkum, Netherlands
Chris Verslype, Belgium
LEARNING OBJECTIVES
• To learn the bases of diagnosis, characterisation and staging of Neuroendocrine Neoplasms (NENs)
• To understand the essentials in the assessment and the value of multidisciplinary management of patients with NENs
• To understand the diagnostic and therapeutic role of nuclear medicine within the global clinical strategy
• To learn how to integrate and sequence the available therapies in the management of a patient with advanced NENs
ACCREDITATION
The programme of this event has been accredited with 11 ESMO-MORA category 1 points.
Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees
that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary
skills and standards for the practice of medical oncology. For further details, please refer to esmo.org.
ACKNOWLEDGEMENTS
This event is supported by an unrestricted educational grant from
ORGANISATION AND CONTACTS
ESMO Head Office
Education Department
Via Ginevra 4
6900 Lugano
Switzerland
Email: [email protected]
www.esmo.org
Friday, , , , 14 June 201914 June 201914 June 201914 June 2019
09:0009:0009:0009:00----09:2009:2009:2009:20 Welcome and course overviewWelcome and course overviewWelcome and course overviewWelcome and course overview
20ʼ Nicola Fazio, IT and Juan Valle, UK
09:209:209:209:20000----11:1011:1011:1011:10 Session 1Session 1Session 1Session 1
Terminology, diagnosis, characterisation and stagingTerminology, diagnosis, characterisation and stagingTerminology, diagnosis, characterisation and stagingTerminology, diagnosis, characterisation and staging
25ʼ Role of pathology
Massimo Milione, IT
25ʼ Role of radiology
Guido Bonomo, IT
25ʼ Role of nuclear medicine
Prakash Manoharan, UK
10ʼ Clinical features
Simona Glasberg, IL
25ʼ Discussion
Faculty
11:10-11:30 Coffee break
11:11:11:11:30303030----13:2013:2013:2013:20 Session 2Session 2Session 2Session 2
Therapeutic approachTherapeutic approachTherapeutic approachTherapeutic approach
15ʼ General criteria of therapeutic strategy
Nicola Fazio, IT
25ʼ How “functionality” makes a difference to patient care
Simona Glasberg, IL
20ʼ Systemic antitumour therapies
Jaume Capdevila Castillon, ES
20ʼ Peptide Receptor Radionuclide Therapy (PRRT)
Prakash Manoharan, UK
30ʼ Discussion
Faculty
13:20-14:20 Lunch
11114:204:204:204:20----15:15:15:15:55550000 Session 3Session 3Session 3Session 3
How to manage specific clinical situationsHow to manage specific clinical situationsHow to manage specific clinical situationsHow to manage specific clinical situations
25ʼ Clinical management of low grade Gastroenteropancreatic (GEP) NENs
Chris Verslype, BE
25ʼ Clinical management of intermediate grade GEP NENs
Nicola Fazio, IT
25ʼ Clinical management of high grade GEP NENs
Juan Valle, UK
15ʼ Discussion
Faculty
15:50-16:05 Coffee break
16:0516:0516:0516:05----11117:057:057:057:05 Session 4Session 4Session 4Session 4
Novel therapiesNovel therapiesNovel therapiesNovel therapies
15ʼ New Tyrosine Kinase Inhibitors (TKIs)
Jaume Capdevila Castillon, ES
Session 4Session 4Session 4Session 4 ---- cont.cont.cont.cont.
Novel therapiesNovel therapiesNovel therapiesNovel therapies
15ʼ Primary tumour removal in metastatic disease
Els Nieveen van Dijkum, NL
15ʼ Clinical trials of medical therapies combined with PRRT
Chris Verslype, BE
15ʼ Discussion
Faculty
17:0517:0517:0517:05----17:5017:5017:5017:50 Session 5Session 5Session 5Session 5
LiverLiverLiverLiver----directed treatmentsdirected treatmentsdirected treatmentsdirected treatments
15ʼ Interventional radiology procedures
Guido Bonomo, IT
15ʼ Liver metastasectomy
Els Nieveen van Dijkum, NL
15ʼ Discussion
Faculty
19:30 Dinner
Saturday, , , , 15 June 201915 June 201915 June 201915 June 2019
09:0009:0009:0009:00----12:3012:3012:3012:30 WorkshopWorkshopWorkshopWorkshop sessionssessionssessionssessions
Three parallel workshop sessions with around 20 delegates in each group (delegates will attend all 3
sessions on a rotation basis)
15ʼ Introduction based on clinical cases presented by speakers
40ʼ Discussion
5ʼ Break
Workshop 1Workshop 1Workshop 1Workshop 1 Challenges in diagnosis, characterisation and stagingChallenges in diagnosis, characterisation and stagingChallenges in diagnosis, characterisation and stagingChallenges in diagnosis, characterisation and staging
60ʼ Guido Bonomo, IT
Simona Glasberg, IL
Massimo Milione, IT
Workshop 2Workshop 2Workshop 2Workshop 2 Practical application of nuclear medicine theranostic approachPractical application of nuclear medicine theranostic approachPractical application of nuclear medicine theranostic approachPractical application of nuclear medicine theranostic approach
60ʼ Nicola Fazio, IT
Prakash Manoharan, UK
Chris Verslype, BE
Workshop 3Workshop 3Workshop 3Workshop 3 Integrating therapy Integrating therapy Integrating therapy Integrating therapy choiceschoiceschoiceschoices for advafor advafor advafor advanced diseasenced diseasenced diseasenced disease
60ʼ Jaume Capdevila Castillon, ES
Juan Valle, UK
Els Nieveen van Dijkum, NL
11:00-11:30 Coffee break
12:3012:3012:3012:30----13:0013:0013:0013:00 Feedback on the workshopFeedback on the workshopFeedback on the workshopFeedback on the workshopssss from each groupfrom each groupfrom each groupfrom each group
13:0013:0013:0013:00----13:13:13:13:30303030 Synthesis and wrapSynthesis and wrapSynthesis and wrapSynthesis and wrap----upupupup
30ʼ Nicola Fazio, IT and Juan Valle, UK
13:30-14:30 Lunch